BioSig Technologies today announced that it is partnering with Summit Blue Capital to implement a leasing and finance program for the company’s Pure EP system. Minneapolis-based Summit Blue Capital offers tailored leasing and financing for partners and clients in healthcare, manufacturing, hospitality, technology and more. Through the partnership, BioSig will be able to offer a […]
BioSig Technologies
BioSig Technologies announces $3M offering
BioSig Technologies (Nasdaq:BSGM) announced today that it entered into a definitive purchase agreement to sell $3 million in common stock. Westport, Connecticut-based BioSig agreed to sell $3 million in common stock and warrants in the agreement led by a family office with expertise in small-cap emerging growth investing. Under the agreement, BioSig will issue 2,611,739 […]
BioSig Technologies appoints former Abbott executive as chief operating officer
BioSig Technologies (NSDQ:BSGM) today announced that it has appointed John Sieckhaus as chief operating officer. Sieckhaus joins BioSig — a creator of a proprietary biomedical signal processing platform — with 30 years of experience in the healthcare industry. He has served in numerous leadership roles at St. Jude Medical and Abbott Labs, including SVP and GM. […]
BioSig Technologies appoints chief commercial officer
BioSig Technologies today announced that it has appointed Gray Fleming as chief commercial officer. Most recently, Fleming served as chief commercial officer at Carecube, which is developing a temporary and scalable negative pressure isolation technology. “I am extremely excited to be returning to the electrophysiology arena and, most importantly, dedicating effort and energy towards supporting […]
BioSig, Mayo Clinic announce AI development partnership
BioSig Technologies (NSDQ:BSGM) will work with the Mayo Foundation for Medical Education and Research to develop next-gen, AI-powered software for its Pure EP system, which is meant to take electrophysiology to the next level. The Mayo Clinic has already been an important investor and development partner for the Westport, Conn.–based company. BioSig signed a 10-year collaboration […]
BioSig closes $17.5m offering
BioSig Technologies (NSDQ:BSGM) announced today that it closed a registered direct offering of common stock worth $17.5 million. The Westport, Conn.-based company and its majority-owned subsidiary, ViralClear Pharmaceuticals, sold nearly 2.2 million shares of common stock at $8 per share, closing the offering on June 26. Proceeds from the offering reached $17.5 million before deducting placement […]
BioSig Technologies announces 100th patient case with its ECG booster
BioSig Technologies (NSDQ:BSGM) announced today that it successfully completed 100 patient cases with its Pure EP electrocardiographic system. The Pure EP is designed to acquire, digitize, measure, display and store electrocardiographic and intracardiac signals for patients undergoing electrophysiology procedures. Westport, Conn.–based BioSig initiated its first clinical trial in November 2019 and is currently enrolling at the Texas […]
BioSig signs licensing agreements with Mayo Clinic
BioSig Technologies (NSDQ:BSGM) announced today that it agreed to three new patent and know-how license agreements with the Mayo Foundation for Medical Education and Research. Under the agreements, BioSig plans to establish a new product pipeline for its Pure EP system for acquiring, digitizing, measuring, displaying and storing electrocardiographic and intracardiac signals for patients undergoing electrophysiology […]
BioSig opens new office in Rochester, Minn.
BioSig Technologies (NSDQ:BSGM) said yesterday that it is opening a technology development office in Rochester, Minn., in collaboration with Mayo Clinic. Westport, Conn.-based BioSig said its new office will serve as an R&D and product development hub in support of the projects developed through its strategic collaboration with Mayo Clinic and Mayo Ventures. Mayo Clinic, having […]
BioSig’s NeuroClear Technologies raises nearly $4m
BioSig Technologies (NSDQ:BSGM) said last week that its subsidiary, NeuroClear Technologies, raised nearly $4 million in an initial seed-funding round. NeuroClear said it intends to use the proceeds from the $3.7 million round to fund product development and initial pre-clinical studies, development of its intellectual property portfolio and for general corporate purposes. Founded in November 2018, […]
BioSig lands $1M investment from Mayo Clinic
Cardiac arrhythmia-detection startup BioSig Technologies (NSDQ:BSGM) has received nearly $1 million in financing from the Mayo Clinic after working with the healthcare organization for two years. BioSig recently completed first-in-human studies at the Rochester, Minn.-based clinic aimed at validating the safety and efficacy of its Pure EP system during mapping and ablation procedures in a cardiac EP lab. Patient […]
